US Patent 11926825 Compounds and methods for reducing ATXN2 expression
Patent 11926825 was granted and assigned to Ionis Pharmaceuticals on March, 2024 by the United States Patent and Trademark Office.
Name
# Contributions
Last Contribution
Find more entities like US Patent 11926825 Compounds and methods for reducing ATXN2 expression
Use the Golden Query Tool to find similar entities by any field in the Knowledge Graph, including industry, location, and more.
By using this site, you agree to our Terms of Service.